Tapering csDMARDs in RA remission fails to achieve non-inferiority vs. stable dose
Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority vs. stable dosage, according to data. “An increasing number of patients with rheumatoid arthritis achieve sustained remission, even when using first-line treatment with methotrexate and other